SEARCH

SEARCH BY CITATION

References

  • 1
    Mitchell JF. Pharmacist involvement as a member of a renal transplant team. Am J Hosp Pharm 1976; 33: 5558.
  • 2
    Jones RA, Lopez LM, Beall DG. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic. Hosp Pharm 1991; 26: 778782.
  • 3
    Peterson CD, Lake KD. Reducing prophylactic antibiotic costs in cardiovascular surgery: the role of the clinical pharmacist. Drug Intell Clin Pharm 1986; 20: 134137.
  • 4
    Miyagawa CI, Rivera JO. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit. Am J Hosp Pharm 1986; 43: 30083013.
  • 5
    Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm 1988; 22: 252259.
  • 6
    Bertch KE, Hatoum HT, Willett MS, Witte KW. Cost justification of clinical pharmacy services on a general surgery team: focus on diagnosis-related group cases. Drug Intell Clin Pharm 1988; 22: 906911.
  • 7
    Chrischilles EA, Helling DK, Aschoff CR. Effect of clinical pharmacy services on the quality of family practice physician prescribing and medication costs. DICP 1989; 23: 417421.
  • 8
    Mueller BA, Abel SR. Impact of college of pharmacy-based educational services within the hospital. DCIP 1990; 24: 422425.
  • 9
    Garrelts JC, Smith DF Jr. Clinical services provided by staff pharmacists in a community hospital. Am J Hosp Pharm 1990; 47: 20112015.
  • 10
    Thornton JP, Goff DA, Segal R, Guy JT. Impact of a clinical pharmacist on antibiotic prescribing. A multicenter trial. J Pharm Technol 1991; 7: 195200.
  • 11
    Taylor JT, Kathman MS. Documentation of cost savings from decentralized clinical pharmacy services at a community hospital. Am J Hosp Pharm 1991; 48: 14671470.
  • 12
    Haig GM, Kiser LA. Effect of pharmacist participation on a medical team on costs, charges, and length of stay. Am J Hosp Pharm 1991; 48: 14571462.
  • 13
    Torok N, Brown G. The economic impact of clinical pharmacists’ unsolicited recommendations. Hosp Pharm 1992; 27: 10561058.
  • 14
    Chuang LC, Sutton JD, Henderson GT. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit. Hosp Pharm 1994; 29: 215218.
  • 15
    Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994; 22: 10441048.
  • 16
    Anonymous. The United Network of Organ Sharing Bylaws. Attachment 1 to Appendix B of the UNOS Bylaws; Designated Transplant Program Criteria. UNOS-Appendix B-Attachment I–XIII-1-91.
  • 17
    [UNOS] United Network for Organ Sharing. 2007. Attachment 1 to Appendix B of UNOS Bylaws: designated transplant program criteria. Available at http://www.unos.org/policiesandBylaws2/bylaws/UNOSByLaws/pdfs/bylaw_122.pdf. Accessed November 6, 2009.
  • 18
    Anonymous. Department of Health and Human Services, Centers for Medicare & Medicaid Services 42 CFR Parts 405, 482, 488, and 498 Medicare Program; Hospital Conditions of Participation: Requirements for Approval and Re-Approval of Transplant Centers To Perform Organ Transplants; Final Rule. Federal Register 2007; 72(61): 1519715279.
  • 19
    Anonymous. Title 42 of the Public Health Service Act. Part 121 – Organ Procurement and Transplantation Network. Washington , D.C. Sections 215, 371–376 of the Public Health Service Act (42 U.S.C. 216, 273–274d); sections 1102, 1106, 1138 and 1871 of the Social Security Act (42 U.S.C. 1302, 1306, 1320b–8 and 1395hh); and section 301 of the National Organ Transplant Act, as amended (42 U.S.C. 274e).
  • 20
    Immunology/Transplantation Practice and Research Network (PRN) history report.2009. Available at http://www.accp.com/prns/history.aspx. Accessed November 6, 2009.
  • 21
    Required Educational Outcomes G, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Solid Organ Transplant. Bethesda, MD: American Society of Health-System Pharmacists, 2008. Available at http://www.ashp.org/s_ashp/docs/files/accreditation/RTP_ObjTransplant032608.doc. Accessed September 10, 2009.
  • 22
    De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transplant Int 2009; 22: 780797.
  • 23
    De Geest S, Dobbels F, Fluri C, Paris W, Troosters T. Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs 2005; 20: S88S98.
  • 24
    Denhaerynck K, Dobbels F, Cleemput I et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transplant Int 2005; 18: 11211133.
  • 25
    Dobbels F, Ruppar T, De Geest S, Decorte A, Van Damme-Lombaerts R, Fine RN. Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant 2010; 14: 603613.
  • 26
    Horn E and Jacobi J. The critical care clinical pharmacist: evolution of an essential team member. Crit Care Med 2006; 34: S46S51.
  • 27
    Burckart GJ. Transplant pharmacy: 30 years of improving patient care. Ann Pharmacother 2007; 41: 12611263.
  • 28
    Martin JE, Zavala EY. The expanding role of the transplant pharmacist in the multidisiplinary practice of transplantation. Clin Transplant 2004; 2004: 5054.
  • 29
    Chisholm MA, Mulloy LL, Lagadeesan M, DiPiro JT. Impact of clinical pharmacy services on renal transplant patients’ compliance wiht immunosuppressive medications. Clin Transplant 2001; 15: 330336.
  • 30
    Chisholm MA, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis 2002; 12: 392397.
  • 31
    Wang HY, Chan ALF, Chen MT, Liao CH, Tian YF. Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics. Transplant Proc 2008; 40: 23192323.
  • 32
    Ciminelli AM, Dupuis R, Williams D. Patient education role of a pharmacist on a transplant service. Am J Health Syst Pharm 2000; 57: 767768.
  • 33
    Costanzo MR, Dipchand A, Starling R et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29: 914956.